Capital Research & Management Co – ‘SC 13G/A’ on 2/13/08 re: Adeza Biomedical Corp

On:  Wednesday, 2/13/08, at 11:28am ET   ·   Accession #:  17283-8-116   ·   File #:  5-46611

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Amendment to Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G/A    Amendment to Statement of Beneficial Ownership         4     18K 

Document Table of Contents

SC 13G/A
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
UNITED STATES         
SECURITIES AND EXCHANGE COMMISSION          
Washington, D.C. 20549          

SCHEDULE 13G          

Under the Securities Exchange Act of 1934         

(Amendment No. 1)*          

Adeza Biomedical Corp       
(Name of Issuer)      

Common Stock      
(Title of Class of Securities)      

006864102       
(CUSIP Number)      

December 31, 2007       
(Date of Event Which Requires Filing of this Statement)       

Check the appropriate box to designate the rule pursuant to which this          
Schedule is filed:                                                              
[X] Rule 13d-1(b)                                                               
[ ] Rule 13d-1(c)                                                               
[ ] Rule 13d-1(d)                                                               

*The remainder of this cover page shall be filled out for a reporting           
person's initial filing on this form with respect to the subject class          
of securities, and for any subsequent amendment containing information          
which would alter the disclosures provided in a prior cover page.               

The information required in the remainder of this cover page shall not          
be deemed to be "filed" for the purpose of Section 18 of the Securities         
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of         
that section of the Act but shall be subject to all other provisions of         
the Act (however, see the Notes).                                               

CUSIP: 006864102                                                Page 1 of 5     

SC 13G/A
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
1   NAMES OF REPORTING PERSONS                                                
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)           
Capital Research and Management Company                               

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE                     
INSTRUCTIONS)                                                 (a)     

                                                           (b)
3   SEC USE ONLY                                                              

4   CITIZENSHIP OR PLACE OF ORGANIZATION                                      

Delaware                                                              

5   SOLE VOTING POWER                                 

NONE                                        

6   SHARED VOTING POWER                               
NUMBER OF                                                                     
SHARES         NONE                                                       
BENEFICIALL                                                                     
Y OWNED BY                                                                    
7   SOLE DISPOSITIVE POWER                            
EACH                                                                    
REPORTING        NONE                                                         
PERSON                                                                    
WITH:                                                                     
8   SHARED DISPOSITIVE POWER                          

NONE                                        

9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON              

NONE  PLEASE NOTE: Capital Research and Management Company (CRMC)     
manages assets subject to reporting on Schedule 13G through two       
investment divisions, Capital Research Global Investors (CRGI) and    
Capital World Investors (CWI).  CRGI and CWI make independent         
investment and proxy voting decisions, and therefore have begun       
filing separate ownership reports on Schedule 13G reflecting December 
31, 2007 holdings in lieu of CRMC filing.  As CRMC is no longer       
subject to a reporting requirement, it is filing reports indicating   
0% ownership to close out its holdings and will cease making future   
filings as an entity.  Note that CRGI and/or CWI may not have made    
filings for certain securities held as of December 31, 2007 because   
one or both divisions did not have a reporting obligation with        
respect to such securities.                                           
10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES      
(SEE INSTRUCTIONS)                                                    

11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9                           

0.0%  See explanation in Row 9                                        

CUSIP: 006864102                                                Page 2 of 5     

SC 13G/A
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
12  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                               

IA                                                                    

CUSIP: 006864102                                                Page 3 of 5     

SECURITIES AND EXCHANGE COMMISSION          
Washington, DC 20549          

Schedule 13G          
Under the Securities Exchange Act of 1934         

Amendment No. 1                                                                 

Item 1(a)     Name of Issuer:                                                   
Adeza Biomedical Corp                                             

Item 1(b)     Address of Issuer's Principal Executive Offices:                  
1240 Elko Drive                                                   
Sunnyvale CA 94089                                                

Item 2(a)     Name of Person(s) Filing:                                         
Capital Research and Management Company                           

Item 2(b)     Address of Principal Business Office or, if none,                 
Residence:                                                        
333 South Hope Street                                             
Los Angeles, CA  90071                                            

Item 2(c)     Citizenship:   N/A                                                

Item 2(d)     Title of Class of Securities:                                     
Common Stock                                                      

Item 2(e)     CUSIP Number:                                                     
006864102                                                         

Item 3     If this statement is filed pursuant to sections 240.13d-1(b)         
or 240.13d-2(b) or (c), check whether the person filing is a:     
(e)      [X]     An investment adviser in accordance with         
section 240.13d-1(b)(1)(ii)(E).                         

Item 4     Ownership                                                            

Provide the following information regarding the aggregate         
number and percentage of the class of securities of the issuer    
identified in Item 1.                                             

(a)    Amount beneficially owned:                                 
(b)    Percent of class:                                          
(c)    Number of shares as to which the person has:               
(i)    Sole power to vote or to direct the vote:                  
(ii)   Shared power to vote or to direct the vote:                
(iii)  Sole power to dispose or to direct the disposition of:     
(iv)   Shared power to dispose or to direct the disposition of:   

See page 2                                                        

Item 5     Ownership of Five Percent or Less of a Class.  If this               
statement is being filed to report the fact that as of the date   
hereof the reporting person has ceased to be the beneficial       
owner of more than five percent of the class of securities,       
check the following: [X]                                          

CUSIP: 006864102                                                Page 4 of 5     

SC 13G/A
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
Item 6     Ownership of More than Five Percent on Behalf of Another             
Person: N/A                                                       

Item 7     Identification and Classification of the Subsidiary Which            
Acquired the Security Being Reported on By the Parent Holding     
Company or Control Person. : N/A                                  

Item 8     Identification and Classification of Members of the Group:           
N/A                                                               

Item 9     Notice of Dissolution of Group:  N/A                                 

Item 10     Certification                                                       

By signing below, I certify that, to the best of my knowledge     
and belief, the securities referred to above were acquired and    
are held in the ordinary course of business and were not          
acquired and are not held for the purpose of or with the effect   
of changing or influencing the control of the issuer of the       
securities and were not acquired and are not held in connection   
with or as a participant in any transaction having that purpose   
or effect.                                                        

Signature                                                             

After reasonable inquiry and to the best of my knowledge and      
belief, I certify that the information set forth in this          
statement is true, complete and correct.                          

Date:          February 13, 2008                                

Signature:     Paul G. Haaga, Jr.^                              
Name/Title:    Paul G. Haaga, Jr. - Vice Chairman               
     Capital Research and Management Company

^By    /s/ Kenneth R. Gorvetzian                                
Kenneth R. Gorvetzian                             
Attorney-in-fact                                  

Signed pursuant to a Power of Attorney dated December 21,   
2007 included as an Exhibit to Schedule 13G filed with the  
Securities and Exchange Commission by Capital Research and  
Management Company on January 10, 2008 with respect to Lowes
Companies, Incorporated.                                    

CUSIP: 006864102                                                Page 5 of 5     

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘SC 13G/A’ Filing		Date		First		Last			Other Filings
Filed on:		2/13/08		4					SC 13G/A
		1/10/08		4					SC 13G/A
		12/31/07		1		2			13F-NT
		12/21/07		4
									List all Filings